ADMP | Adamis Pharmaceuticals Corp
Category: Consumer goods
Industry: Drug Manufacturers - Specialty & Generic Quick infos Headquarters: California, United States Trade prices Volume: Market Cap: 134.74M Prev closed: 0.52 Open: 0.52 High: 0.52 Low: 0.49 52 week low: 0.27 52 week high: 1.51 Dividends: Next ER: November 22, 2021
Earnings History Date EPS / Forecast Revenue / Forecast March 31, 2022 November 22, 2021 -0.12 / -0.044.11M / 3.3MBeat! August 31, 2021 - / -0.05- / 3.09MMay 17, 2021 -0.05 / -0.0551.23M / 3.47MApril 16, 2021 -0.255 / -0.05673.6M / 6.01Mview more
Historical Data Date Price Open High Low Vol Change ER Jan 13, 2022 0.6140 0.6700 0.6800
0.6102
1.03M -8% Jan 12, 2022 0.6674 0.6767 0.7100
0.6503
2.39M -2.01% Jan 11, 2022 0.6811 0.7100 0.7295
0.6655
3.86M -6.7% Jan 10, 2022 0.7300 0.6074 0.8477
0.6068
38.37M 26.96% Jan 7, 2022 0.5750 0.5599 0.5911
0.5550
755.32K -0.24% Jan 6, 2022 0.5764 0.5760 0.5801
0.5510
972.89K -1.28% Jan 5, 2022 0.5839 0.6250 0.6398
0.5751
1.44M -7.49% Jan 4, 2022 0.6312 0.6191 0.6485
0.5919
1.63M 1.48% Jan 3, 2022 0.6220 0.6150 0.6347
0.5700
1.25M 2.81% Dec 31, 2021 0.6050 0.5770 0.6517
0.5701
2.85M 3.99% view more
NASDAQ - Nasdaq Stock Market
News
Should You Observe this stock? Adamis Pharmaceuticals ... reporter.am Dec 15, 2020 2:19 pm Attention Biotech Investors: Mark Your Calendar For ... benzinga.com Nov 30, 2020 2:19 pm 3 Penny Stocks To Buy For Under $3; Are They Worth The Risk? pennystocks.com Nov 30, 2020 2:19 pm Will Adamis Pharmaceuticals (ADMP) Report Negative Q3 Earnings? What You Should Know finance.yahoo.com Nov 21, 2020 2:19 pm Adamis Pharmaceuticals prices equity offering, shares down 13% seekingalpha.com Sep 18, 2020 9:19 pm Adamis Pharmaceuticals under pressure after public offering seekingalpha.com Sep 18, 2020 4:12 am Adamis Pharmaceuticals Announces Pricing of Public Offering ... globenewswire.com Sep 18, 2020
Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update finance.yahoo.com Aug 28, 2020 4:30 pm
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update finance.yahoo.com Aug 28, 2020 4:28 pm Aquestive launches early-stage study of sublingual epinephrine for allergic reactions seekingalpha.com Aug 20, 2020 8:05 pm
Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release finance.yahoo.com Aug 28, 2020 10:30 am
Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI finance.yahoo.com Aug 28, 2020 9:30 am
Masimo (MASI) to Report Q2 Earnings: What's in the Offing? finance.yahoo.com Aug 28, 2020 9:12 am
Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA finance.yahoo.com Aug 28, 2020 9:00 am
FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose finance.yahoo.com Aug 28, 2020 8:12 am
The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA finance.yahoo.com Aug 28, 2020 7:39 am
Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders and Proposals finance.yahoo.com Aug 25, 2020 9:00 am Adamis Pharmaceuticals EPS misses by $0.07, misses on revenue seekingalpha.com Aug 18, 2020 4:45 am Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates finance.yahoo.com Aug 17, 2020
Adamis Pharmaceuticals Announces Pre-IND Feedback from FDA Enabling Advancement of Tempol, a Novel Anti-Inflammatory and Anti-Oxidant Drug for the Treatment of COVID-19 finance.yahoo.com Aug 14, 2020 9:00 am Talk about Adamis Pharmaceuticals Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
ir.adamispharmaceuticals.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
